Chongqing Yihao Pharmaceutical Co., Ltd. ("Chongqing Yihao"), a subsidiary of 111 Inc. (YI.US), has been recognized for the third consecutive year in the 2025 Chongqing Top 100 Service Enterprises ranking, underscoring its leadership and operational excellence in pharmaceutical distribution.
Established in 2018 in Chongqing Liangjiang New Area, Chongqing Yihao serves as 111 Inc.’s strategic hub in Southwest China. It has evolved into a modern pharmaceutical distributor offering over 200,000 products, including medicines, medical devices, and health supplements. Leveraging large-scale intelligent warehousing and integrating 111 Inc.’s capabilities in smart supply chains, digital marketing, and user management, the company has built an omnichannel pharmaceutical service network.
With sustained government support, Chongqing Yihao has achieved rapid growth, reporting annual revenue of RMB 2.9 billion in 2024. Its 25,000-square-meter specialized warehouse ensures operational efficiency. The company now serves over 500,000 pharmacies nationwide, covering approximately 90% of China’s total pharmacy market.
Through 111 Inc.’s digital platform "1 Drug City®," retail pharmacies gain access to competitive pricing and streamlined sourcing, while pharmaceutical manufacturers benefit from a high-efficiency supply chain enabling 24-hour delivery across 890 cities and counties.
As 111 Inc.’s Southwest operational center, Chongqing Yihao continues to consolidate regional resources, accelerating the distribution of quality medical products nationwide in alignment with China’s health initiatives.
Founded in 2010, 111 Inc. operates an integrated healthcare ecosystem comprising online pharmacy "111.com," offline stores, telemedicine service "1 Clinic Health," digital distribution platform "1 Drug City®," and SaaS-based "1 Health Together." The company partners with 500+ global pharmaceutical firms and serves 90% of China’s pharmacies via "1 Drug City®."
111 Inc. went public on Nasdaq (ticker: YI) on September 12, 2018, becoming China’s first internet-based healthcare firm listed in the U.S.